diagnosis MS

September 2006
PN;Sep2006, Vol. 60 Issue 9, p22
Trade Publication
The article focuses on the Multiple Sclerosis (MS) Lesion Project. The project was formed to address varied responses of individuals with MS to different types of treatment. Scientists in the U.S., Germany and Austria are evaluating tissue from MS lesions and comparing findings on the person's records of actual symptoms and disabilities. Four distinct lesion patterns in MS have been discovered. Findings on the MS Lesion Project is presented.


Related Articles

  • What Is Progressive MS? Wolinsky, Jerry // Inside MS;Jan2005, Vol. 23 Issue 1, p56 

    Discusses the symptoms and clinical features of progressive multiple sclerosis (MS). Difference between primary-progressive MS and secondary-progressive MS; Accumulation of disability in people with relapsing-remitting MS in a slow manner; Diagnostic criteria used to determine if a person has a...

  • ANALÝZA VPLYVU PRAVIDELNEJ FYZIOTERAPIE NA ÚROVEŇ ÚNAVY PACIENTOV SO SCLEROSIS MULTIPLEX S RÔZNYM STUPŇOM INVALIDITY. Mikuláková, W.; Klímová, E. // Rehabilitation & Physical Medicine / Rehabilitace a Fyzikalni Le;Dec2012, Vol. 19 Issue 4, p159 

    Fatigue is considered as one of the main symptoms burdening patients with multiple sclerosis (MS). The objective of the research was to investigate the impact of fatigue on physical, cognitive and psychosocial areas of MS patientęs life, and also to focus on the importance of physiotherapy...

  • EVEN THE RAIN stung my skin. Catalano, Anita; Brown, Emma-Charlotte // Woman's Day (Australia Edition);6/2/2003, p56 

    Presents an article on being diagnosed with multiple sclerosis (MS). Symptoms associated with MS: Initial reaction to the diagnosis; Treatment regime for MS.

  • Changing Paradigms in MS Therapies. Corboy, John R. // Journal of Managed Care Medicine;2014, Vol. 17 Issue 1, p16 

    No abstract available.

  • Multiple Sclerosis Not as Progressive or Disabling as Once Thought.  // Ascribe Newswire: Medicine;1/22/2004, p15 

    In the most comprehensive study of how multiple sclerosis symptoms change over time, researchers at Mayo Clinic, Rochester, Minnesota have found that less than half of patients studied developed worsening disability within 10 years. Knowing how the symptoms of MS change over time provides good...

  • an Overview of MS. Guarnaccia, Joseph B.; Booss, John // PN;Feb2005, Vol. 59 Issue 2, p32 

    Presents facts and information about multiple sclerosis. Clinical definition; People that are afflicted by multiple sclerosis and its genetic factors; Diagnosis and symptoms; Prospects for multiple sclerosis treatments. INSET: NEW EDITION OF MS WELLNESS GUIDE.

  • Which Factors Predict Whether a Patient With MS Will Switch Therapies? Greb, Erik // Neurology Reviews;Nov2013, Vol. 21 Issue 11, p20 

    The article focuses on the predictor responsible for switching from a first-line disease modifying therapy (DMT) for patients suffering from recurring multiple sclerosis (MS). It mentions that patients who switched therapies were at the native stages of symptom onset and younger at DMT...

  • Managing the Adverse Effects of Interferon-β Therapy in Multiple Sclerosis. Bayas, A.; Rieckmann, P. // Drug Safety;Feb2000, Vol. 22 Issue 2, p149 

    Interferon-β is an established therapy in relapsing-remitting multiple sclerosis. Recently, it has also been shown that interferon-β-1b is effective in secondary progressive multiple sclerosis. However, adverse effects of interferon-β treatment are common, particularly during the first...

  • Multiple Sclerosis.  // New Harvard Guide to Women's Health;2004, p393 

    Presents a comprehensive women's health guide to multiple sclerosis (MS), a crippling disease of the central nervous system. Pathophysiology; Prognosis for people with MS; Epidemiology and symptoms; Treatment options for a variety of MS symptoms.

  • What's Going On with the disease-modifying drugs? Nauen, Elinor // Inside MS;Dec2006/Jan2007, Vol. 24 Issue 6, p40 

    The article examines the use of disease-modifying multiple sclerosis (MS) drugs in the U.S. Most MS specialists recommend early treatment with disease-modifying agents for people with relapsing forms of MS. Studies have demonstrated that, used as prescribed, most people benefit from...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics